The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be fu ...

Panelists discuss exciting updates on Bruton tyrosine kinase (BTK) inhibitors from the 2024 American Society of Hematology ...

Rusfertide: Protagonist held an in-person PV Day on February 6, 2025, in New York; The topline data for the Phase 3 VERIFY study in PV, which ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Candel Therapeutics' lead candidate CAN-2409 shows promising results in several indications. Find out why I rate CADL stock ...

Massachusetts General Hospital coordinated the first four platform trials within the HEALEY ALS platform to evaluate ...

Objective This study aims to calculate the global warming potential, in carbon dioxide (CO 2) equivalent emissions, from all in-scope activities involved in phase 1, 2, 3 and 4 clinical trials ...

Layoffs, funding freezes, and executive orders spark outcry among federal researchers and university partners, fearing that ...

Company shares preliminary results from Phase 1/2 clinical trial for patients with advanced Retinitis Pigmentosa (RP)NEW YORK, Feb. 18, 2025 ...

The first of Opthea’s (ASX:OPT) two phase III eye disease trials has hit a key development milestone, with the last patient ...

IQVIA has seen an increase of 58.97% in its revenues since 2017. Click here to read more about IQV stock and why it is rated ...